Article: DispersinB(R) Overproduction Using a Novel Approach Published in the Journal of Industrial Microbiology & Biotechnology.

WINNIPEG, MANITOBA, Jul 21, 2009 (Marketwire via COMTEX) -- Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms is pleased to announce that some of its ongoing internal research on the Company's patented DispersinB(R) antibiofilm technology has been published in the latest online edition of the Journal of Industrial Microbiology & Biotechnology (DOI 10.1007/s10295-009-0613-0; Impact Factor: 2.0).

The publication, entitled "Enhanced expression of engineered ACA-less Beta-1,6-N-acetylglucosanimidase (dispersin B) in Escherichia coli" authored by Dr. Nandadeva Yakandawala et ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!